Avance Clinical在2022年生物技术展上宣布为美国扩张进行重大私募股权投资
Jan 19, 2022 07:00 HKT |  |
|
Avance Clinical在2022年生物技術展上宣佈為美國擴張進行重大私募股權投資
Jan 19, 2022 07:00 HKT | |
|
아방스 클리니컬 바이오테크 쇼케이스 2022에서 미국에서의 확장을 위한 대규모적인 PE 투자를 발표
Jan 19, 2022 07:00 HKT | |
|
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Jan 18, 2022 13:00 HKT | |
|
冠科美博 (Apollomics Inc.) 将于 2022 年 1 月 26-27 日（周三、周四）举办线上投资者活动
Jan 12, 2022 09:27 HKT |  |
|
冠科美博 (Apollomics Inc.) 將於 2022 年 1 月 26-27 日（週三、週四）舉辦線上投資者活動
Jan 12, 2022 09:26 HKT | |
|
Apollomics Inc. to Host Virtual Investor Events on Wednesday, January 26, 2022 and Thursday, January 27, 2022
Jan 12, 2022 09:25 HKT | |
|
B-cell lymphoma clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:10 HKT |  |
|
Autism clinical trials now open on the TrialWire Platform
Jan 05, 2022 17:00 HKT | |
|
冠科美博（Apollomics）首席执行官余国良博士当选为百华协会 (BayHelix Group) 董事会主席
Jan 04, 2022 10:12 HKT | |
|
冠科美博（Apollomics）首席執行官余國良博士當選為百華協會 (BayHelix Group) 董事會主席
Jan 04, 2022 10:11 HKT | |
|
Apollomics Inc. Announces CEO Guo-Liang Yu, PhD Appointed as Chairman of the Board for the BayHelix Group
Jan 04, 2022 10:10 HKT | |
|
冠科美博（Apollomics）Uproleselan 注射液（APL-106）用于治疗复发或难治性急性髓系白血病的中国 III 期临床试验第一例受试者成功入组
Nov 22, 2021 10:42 HKT | |
|
冠科美博（Apollomics）Uproleselan 注射液（APL-106）用於治療復發或難治性急性髓系白血病的中國 III 期臨床試驗第一例受試者成功入組
Nov 22, 2021 10:41 HKT | |
|
Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
Nov 22, 2021 10:40 HKT | |
|
Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership
Nov 12, 2021 07:30 HKT |  |
|
Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies - OCT Webinar
Oct 19, 2021 15:00 HKT |  |
|
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Oct 19, 2021 15:00 HKT | |
|
Avance Clinical临床试验合作申办方XWPharma正式开启其XW10508首次人类临床试验，研究快速缓解难治性抑郁症以及慢性疼痛疗法
Oct 19, 2021 15:00 HKT | |
|
Avance Clinical臨床試驗合作申辦方XWPharma正式開啟其XW10508首次人類臨床試驗，研究快速緩解難治性抑鬱症以及慢性疼痛療法
Oct 19, 2021 15:00 HKT | |
|